Applied Therapeutics

APLT55

High Growth

$10.13arrow_drop_up5.63%$0.54

High Growth

APLT55

$10.13

arrow_drop_up5.63%$0.54

High Growth

Performance History

Key Stats
Open	$9.58
Prev. Close	$9.59
EPS	-1.42
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	9.47	10.47
52 Week Range	1.79	10.60

Ratios







EPS	-1.42

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Applied Therapeutics (APLT)

Applied Therapeutics Inc (APLT) is a pharmaceutical company that focuses on developing and commercializing novel therapeutics for the treatment of serious diseases. With a mission to improve the lives of patients with unmet medical needs, Applied Therapeutics is dedicated to developing innovative therapies that target the underlying mechanisms of diseases. The company's pipeline includes candidates for various indications, including diabetic cardiomyopathy, galactosemia, and diabetic retinopathy.

APLT's stock price history has shown significant fluctuations over the years. Investors have witnessed both highs and lows in the stock's performance. It is important to note that past performance is not indicative of future results, and investors should conduct thorough analysis before making any investment decisions.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Shoshana Shendelman Ph.D.
Headquarters: New York
Employees: 22
Exchange: NASDAQ

Keep an eye on Applied Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Applied Therapeutics (APLT) stock price performance year to date (YTD)?

As of the latest data, Applied Therapeutics (APLT) has a year-to-date price change of 178.3%. Over the past month, the stock has experienced a price change of 20.17%. Over the last three months, the change has been 70.54%. Over the past six months, the figure is 144.1%. Looking at a longer horizon, the five-year price change stands at -36.65%.

help

What is Applied Therapeutics 's (APLT) price per share?

The current price per share for Applied Therapeutics (APLT) is $10.13. The stock has seen a price change of $0.54 recently, indicating a 5.63% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Applied Therapeutics (APLT)?

For Applied Therapeutics (APLT), the 52-week high is $10.61, which is 4.73% from the current price. The 52-week low is $1.79, the current price is 465.92% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Applied Therapeutics (APLT) a growth stock?

Applied Therapeutics (APLT) has shown an average price growth of -3.4% over the past three years. It has received a score of 94 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Applied Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

Is Applied Therapeutics (APLT) a profitable company?

Applied Therapeutics (APLT) has a net income of -$119.76M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -24.38K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $9.99M, although specific revenue growth data is currently not available. Operating income is noted at -$64.54M. Furthermore, the EBITDA is -$92.28M.

help

What is the market capitalization of Applied Therapeutics (APLT)?

Applied Therapeutics (APLT) has a market capitalization of $1.18B. The average daily trading volume is 10.14, indicating the stock's liquidity and investor engagement.